Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001654954-24-014917
Filing Date
2024-11-26
Accepted
2024-11-26 16:30:58
Documents
4
Effectiveness Date
2024-11-26

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tenx_s8.htm S-8 46236
2 OPINION tenx_ex51.htm EX-5.1 5504
3 CONSENT tenx_ex231.htm EX-23.1 2709
4 FEE TABLE tenx_ex107.htm EX-FILING FEES 14690
  Complete submission text file 0001654954-24-014917.txt   70517
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283482 | Film No.: 241504412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)